A new cannabinoid receptor 1 selective agonist evading the 2021 "China ban": ADB-FUBIATA.

MLA

Deventer, Marie H., et al. “A New Cannabinoid Receptor 1 Selective Agonist Evading the 2021 ‘China Ban’: ADB-FUBIATA.” Drug Testing and Analysis, vol. 14, no. 9, Sept. 2022, pp. 1639–44. EBSCOhost, https://doi.org/10.1002/dta.3285.

APA

Deventer, M. H., Van Uytfanghe, K., Vinckier, I. M. J., Reniero, F., Guillou, C., & Stove, C. P. (2022). A new cannabinoid receptor 1 selective agonist evading the 2021 “China ban”: ADB-FUBIATA. Drug Testing and Analysis, 14(9), 1639–1644. https://doi.org/10.1002/dta.3285

Chicago

Deventer, Marie H, Katleen Van Uytfanghe, Inge M J Vinckier, Fabiano Reniero, Claude Guillou, and Christophe P Stove. 2022. “A New Cannabinoid Receptor 1 Selective Agonist Evading the 2021 ‘China Ban’: ADB-FUBIATA.” Drug Testing and Analysis 14 (9): 1639–44. doi:10.1002/dta.3285.